
Enzene Debuts NeX Partnership to Decentralize Biologics Production
A conventional biologics plant demands an investment of up to $400 million, a barrier Enzene aims to shatter with its new NeX platform. By utilizing fully-connected continuous manufacturing, the Pune-based company promises to slash construction costs to between $60 million and $80 million, enabling local production hubs worldwide.






















